Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

Université de Montréal

$120,000.00

The Impact of Pathogenic DNMT3A on Neurodevelopment

EF 2025-26

Résumé
Tatton-Brown-Rahman Syndrome (TBRS) is a rare genetic disorder caused by mutations in the DNMT3A gene. People with TBRS often grow taller, heavier, and have a larger head size. They may have learning difficulties, low muscle tone, heart issues, behavioral challenges, mental health problems, and autism-like traits. Symptoms can vary widely. Many TBRS disabilities are similar to those in other overgrowth and intellectual syndromes, like Weaver, Cohen-Gibson, and Imagawa-Matsumoto, which may share common mechanisms affecting brain cell growth and function. The DNMT3A enzyme is important for the DNA methylation process, a mecanism that controls gene activity by adding chemical tags to DNA. In TBRS, changes in the DNMT3A gene disrupt this process, leading to abnormal gene regulation and causing the syndrome's symptoms. While we know DNMT3A's role, how it leads to the neurodevelopmental problems in TBRS is still unclear. To bridge this knowledge gap, our research team has developed a TBRS mouse model to better understand how the disorder impacts brain cell connections and function, offering valuable insights into the neurological causes of TBRS. This model is designed to elucidate how the mutations in DNMT3A affect neural development and brain function. By adopting an innovative approach, our project has the potential to not only deepen our understanding of the molecular mechanisms behind TBRS but also provide insights into other related overgrowth and intellectual disability syndromes. By studying how DNMT3A mutations affect brain development and function, we can uncover common pathways that may be shared with other disorder syndromes. This will not only advance our understanding of the disorder but also could pave the way for new targeted treatments for TBRS and similar conditions. Our research aims to enhance the quality of life for affected families by providing more precise information and support to that community.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
559357
Name
Clavel Josianne
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
The Impact of Pathogenic DNMT3A on Neurodevelopment
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Behavior; Brain Development; Dna Methylation; Dna Methyltransferase 3a (Dnmt3a); Epigenetics; Mouse Model; Mutation; Neurodevelopment; Rare Disease; Transcriptomics
Abstract
Tatton-Brown-Rahman Syndrome (TBRS) is a rare genetic disorder caused by mutations in the DNMT3A gene. People with TBRS often grow taller, heavier, and have a larger head size. They may have learning difficulties, low muscle tone, heart issues, behavioral challenges, mental health problems, and autism-like traits. Symptoms can vary widely. Many TBRS disabilities are similar to those in other overgrowth and intellectual syndromes, like Weaver, Cohen-Gibson, and Imagawa-Matsumoto, which may share common mechanisms affecting brain cell growth and function. The DNMT3A enzyme is important for the DNA methylation process, a mecanism that controls gene activity by adding chemical tags to DNA. In TBRS, changes in the DNMT3A gene disrupt this process, leading to abnormal gene regulation and causing the syndrome's symptoms. While we know DNMT3A's role, how it leads to the neurodevelopmental problems in TBRS is still unclear. To bridge this knowledge gap, our research team has developed a TBRS mouse model to better understand how the disorder impacts brain cell connections and function, offering valuable insights into the neurological causes of TBRS. This model is designed to elucidate how the mutations in DNMT3A affect neural development and brain function. By adopting an innovative approach, our project has the potential to not only deepen our understanding of the molecular mechanisms behind TBRS but also provide insights into other related overgrowth and intellectual disability syndromes. By studying how DNMT3A mutations affect brain development and function, we can uncover common pathways that may be shared with other disorder syndromes. This will not only advance our understanding of the disorder but also could pave the way for new targeted treatments for TBRS and similar conditions. Our research aims to enhance the quality of life for affected families by providing more precise information and support to that community.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Clavel, Josianne
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~